- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01007799
Vitamin D for Chronic Sinusitis
August 25, 2016 updated by: University of Chicago
A Randomized, Clinical Trial of a Novel Immunotherapy for Chronic Sinusitis: Vitamin D
The purpose of this study is to examine if vitamin D improves the symptoms of chronic sinusitis.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60637
- University of Chicago
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- African American (4 grandparents with AA ancestry)
- Age>18 years
- Diagnosis of chronic sinusitis
Exclusion Criteria:
- Women of childbearing potential not utilizing contraception
- Subjects with contraindications to vitamin D therapy
- History of nephrolithiasis, hypercalcemia, sarcoidosis, recent (3 month) hospitalization
- Use of immunosuppressants/medications that interfere with vitamin D metabolism (e.g., phenytoin and carbamazepine)
- Malignancy
- Kidney, gastrointestinal, or liver disorders
- Immunodeficiency
- Morbid obesity (BMI>35 kg/m2)
- Changes to medications for 6 months prior to study entry
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Placebo
Placebo pills to take for 12 weeks
|
12 weeks of placebo
|
|
Active Comparator: Vitamin D
Vitamin D supplement for 12 weeks
|
12 weeks supplementation based on serum vitamin D levels
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
score on the Sinonasal Outcome Test-22 (SNOT-22)
Time Frame: study onset, mid-point and conclusion
|
study onset, mid-point and conclusion
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Quality of life as measured by SF-36
Time Frame: At entry and at completion of study
|
At entry and at completion of study
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2009
Primary Completion (Actual)
September 1, 2011
Study Completion (Actual)
September 1, 2011
Study Registration Dates
First Submitted
November 3, 2009
First Submitted That Met QC Criteria
November 3, 2009
First Posted (Estimate)
November 4, 2009
Study Record Updates
Last Update Posted (Estimate)
August 26, 2016
Last Update Submitted That Met QC Criteria
August 25, 2016
Last Verified
August 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Infections
- Respiratory Tract Infections
- Respiratory Tract Diseases
- Disease Attributes
- Otorhinolaryngologic Diseases
- Paranasal Sinus Diseases
- Nose Diseases
- Sinusitis
- Chronic Disease
- Physiological Effects of Drugs
- Micronutrients
- Bone Density Conservation Agents
- Calcium-Regulating Hormones and Agents
- Vitamin D
- Cholecalciferol
- Vitamins
- Ergocalciferols
Other Study ID Numbers
- 16601A
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Sinusitis
-
Loma Linda UniversityWithdrawnChronic Sinus Disease | Chronic Sinusitis, Ethmoidal | Chronic Sinusitis, Sphenoidal | Chronic Sinusitis - Maxillary Bilateral | Chronic Sinusitis - Frontoethmoidal
-
LifeBridge HealthUnknownChronic Sinusitis | Nasal Polyps | Chronic Sinusitis, Ethmoidal | Chronic Sinusitis, Sphenoidal | Chronic Sinusitis - Frontoethmoidal | Chronic Sinusitis - Ethmoidal, Posterior | Chronic Sinusitis - Ethmoidal Anterior | Nasal Polyp - PosteriorUnited States
-
Shanghai Yidian Pharmaceutical Technology Development...RecruitingChronic Sinusitis Without Nasal PolypsChina
-
Ayu, Inc.CompletedSinusitis | Rhinosinusitis | Chronic Rhino-sinusitisMalaysia
-
Kaiser PermanenteWithdrawnChronic Sinusitis | Chronic Sinus Infection | Chronic Sinusitis - Ethmoidal, Posterior | Chronic Sinus CongestionUnited States
-
Tampere University HospitalRecruitingMaxillary Sinusitis | Eustachian Tube Dysfunction | Sinusitis, Chronic | Sinusitis RecurrentFinland
-
Collin County Ear Nose & ThroatIntersect ENTCompletedChronic Sinusitis, EthmoidalUnited States
-
Lyra TherapeuticsCompletedChronic Sinusitis | Chronic Rhinosinusitis (Diagnosis)United States, Belgium, Hungary, Germany, Bulgaria, Poland
-
STS MedicalNot yet recruitingChronic Sinusitis, Ethmoidal
-
Optinose US Inc.CompletedChronic Sinusitis With or Without Nasal PolypsUnited States
Clinical Trials on vitamin D placebo
-
The Jerzy Kukuczka Academy of Physical Education...RecruitingVitamin D Deficiency/Insufficiency | Vitamin D 25-Hydroxylase DeficiencyPoland
-
Wroclaw University of Health and Sport SciencesCompletedAthletes | Football Players | Exercise Physiology | Vitamin D Deficiency (10 ng/mL to 30 ng/mL)Poland
-
Universidad Autónoma Benito Juárez de OaxacaNational Council of Science and Technology, MexicoCompletedObesity | Muscle Weakness | Vitamin D Deficiency | Sarcopenia | Aging | Sarcopenic Obesity | Obesity (Disorder) | Sarcopenia in Elderly | Muscle Mass | Functional Decline | Age-Related Loss of Skeletal Muscle Mass | Older Adults (65 Years and Older) | Muscle Strengh | Vitamin D 25-Hydroxylase DeficiencyMexico
-
PfizerTerminated
-
Umeå UniversityRegion SkaneCompleted
-
Queen Mary University of LondonCancer Research UK; Barts and the London School of Medicine and DentistryCompletedProstate CancerUnited Kingdom
-
National Nutrition and Food Technology InstituteCompleted
-
Cornell UniversityArogyavaram Medical CentreNot yet recruiting
-
University of AlexandriaCompletedSystemic Lupus ErythematosusEgypt
-
Tufts Medical CenterAbiogen PharmaNot yet recruitingPrediabetes | Type 2 Diabetes (T2DM)United States